Publications of M. Rex-Haffner

Menke, A.; Klengel, T.; Eichelkraut, A.; Preis, L.; Rex-Haffner, M.; Uhr, M.; Holsboer, F.; Binder, E. B.: Glucocorticoid Induced FKBP5-gene Expression as a Biomarker for Depression? Biological Psychiatry 69 (9 Suppl.1), p. 153 S - 153 S (2011)

Quast, C.; Altmann, A.; Weber, P.; Rex-Haffner, M.; Erhardt, A.; Müller-Myhsok, B.; Binder, E. B.: Screening for rare variants in TMEM132D: a candidate gene from genome-wide association studies in anxiety disorders. European Neuropsychopharmacology 21 (Suppl. 1), pp. S6 - S7 (2011)

Menke, A.; Puetz, B.; Weber, P.; Eichelkraut, A.; Rex-Haffner, M.; Klengel, T.; Gonik, M.; Uhr, M.; Deussing, J.; Holsboer, F. et al.; Müller-Myhsok, B.; Binder, E. B.: Genome-Wide Gene-Expression Profiles Following Glucocorticoid Stimulation Associated with Major Depression. Biological Psychiatry 67 (9 Suppl.1), p. 129S - 129S (2010)

Halldorsdottir, T.; Piechaczek, C.; Pehl, V.; Wagenbuechler, P.; Greimel, E.; Soares de Matos, A. P.; Feldmann, L.; Quickenstedt-Reinhardt, P.; Allgaier, A.-K.; Czamara, D. et al.; Rex-Haffner, M.; Arnarson, E. O.; Craighead, E.; Schulte-Koerne, G.; Binder, E.: Polygenic Risk: Predicting Depressive Symptoms in Clinical and Epidemiological Cohorts of Adolescents. 73rd Annual Scientific Convention and Meeting of the Society-of-Biological-Psychiatry (SOBP), New York, NY, May 10, 2018 - May 12, 2018. BIOLOGICAL PSYCHIATRY 83 (9), F63, p. S262 - S262 (2018)

Ising, M.; Belcredi, P.; Lucae, S.; Tontsch, A.; Namendorf, C.; Uhr, M.; Holsboer, F.; Rex-Haffner, M.; Simulionyte, E.; Hebib, S. et al.; Gruber Oliver, O.; Behler, N.; Nenov-Matt, T.; Schuele, C.; Manook, A.; Heckel, B.; Baghai, T.; Rupprecht, R.: GENOMIC AND IMMUNOLOGICAL BIOMARKERS FOR PREDICTING TREATMENT OUTCOME IN DEPRESSION. In INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 28, p. i314 - i314. (2025)

Karlbauer, V.; Czamara, D.; Martins, J.; Rex-Haffner, M.; Entringer, S.; Winter, S.; Buss, C.; Heim, C.; Binder, E. B.: TARGETED BISULFITE SEQUENCING REVEALS DRIVERS OF FKBP5 METHYLATION IN MALTREATED AND NON-MALTREATED CHILDREN. In EUROPEAN NEUROPSYCHOPHARMACOLOGY, 75, pp. S173 - S174. World Congress of Psychiatric Genetics (WCPG), Montreal, CANADA, October 10, 2023 - October 14, 2023. (2023)

Yusupov, N.; Dieckmann, L.; Erhart, M.; Sauer, S.; Rex-Haffner, M.; Kopf-Beck, J.; Brueckl, T.; Czamara, D.; Binder, E.: Transdiagnostic Evaluation of Epigenetic Age Acceleration and Burden of Psychiatric Disorders. In BIOLOGICAL PSYCHIATRY, 93 (9), p. S166 - S166. (2023)

Dammering, F.; Martins, J.; Hoffmann, F.; Provencal, N.; de Punder, K.; Overfeld, J.; Czamara, D.; Rex-Haffner, M.; McEwen, L.; Kobor, M. et al.; Winter, S.; Buss, C.; Entringer, S.; Binder, E.; Heim, C.: Psychiatric symptom severity mediates the effect of adversity on epigenetic aging in children aged 3-5 years. In Psychoneuroendocrinology, 107, p. 30 - 30. 49th Annual Conference of the International-Society-of-Psychoneuroendocrinology - 50 Years of Psychoneuroendocrinology - Returning to Where It All Began, Milan, ITALY, August 29, 2019 - August 31, 2019. Pergamon, Oxford (2019)

Dammering, F.; Martins, J.; Hoffmann, F.; Provencal, N.; de Punder, K.; Overfeld, J.; Czamara, D.; Rex-Haffner, M.; McEwen, L.; Kobor, M. et al.; Winter, S.; Buss, C.; Entringer, S.; Binder, E.; Heim, C.: Psychiatric symptom severity mediates the effect of adversity on epigenetic aging in children aged 3-5 years. In PSYCHONEUROENDOCRINOLOGY, 107, p. 30 - 30. 49th Annual Conference of the International-Society-of-Psychoneuroendocrinology - 50 Years of Psychoneuroendocrinology - Returning to Where It All Began, Milan, ITALY, August 29, 2019 - August 31, 2019. (2019)

Halldorsdottir, T.; Piechaczek, C.; Soares de Matos, A. P.; Czamara, D.; Pehl, V.; Wagenbuechler, P.; Feldmann, L.; Quickenstedt-Reinhardt, P.; Allgaier, A.-K.; Freisleder, F. J. et al.; Greimel, E.; Kvist, T.; Lahti, J.; Raikkonen, K.; Rex-Haffner, M.; Arnarson, E. O.; Craighead, E.; Schulte-Koerne, G.; Binder, E.: Polygenic risk: predicting depression outcomes in clinical and epidemiological cohorts of youth. In BEHAVIOR GENETICS, 49 (6), p. 556 - 556. 49th Annual Meeting of the Behavior-Genetics-Association (BGA), Karolinska Inst, Stockholm, SWEDEN, June 26, 2019 - June 29, 2019. (2019)

Menke, A.; Beintner, M.; Knop, L.; Rex-Haffner, M.; Uhr, M.; Binder, E. B.: Differentially Dexamethasone-regulated FKBP5 RNA and Protein Expression in Peripheral Blood. In BIOLOGICAL PSYCHIATRY, 77 (9 Suppl.), 616. 70th Annual Scientific Meeting of the Society-of-Biological-Psychiatry on Stress, Emotion, Neurodevelopment and Psychopathology, Toronto, CANADA, May 14, 2015 - May 16, 2015. Elsevier Science Inc., New York, NY 10010-1710 USA (2015)

Menke, A.; Arloth, J.; Best, J.; Rex-Haffner, M.; Holsboer, F.; Uhr, M.; Binder, E. B.: Dexamethasone plasma levels impact glucocorticoid receptors-challenge tests for detection of HPA-axis alterations. In EUROPEAN NEUROPSYCHOPHARMACOLOGY, 25 (Supplement 2), P.1.e.016, p. S218 - S218. 28th Congress of the European-College-of-Neuropsychopharmacology (ECNP), Amsterdam, NETHERLANDS, August 29, 2015 - September 01, 2015. Elsevier Science B.V., Amsterdam, NL (2015)

Klengel, T.; Mehta, D.; Anacker, C.; Rex-Haffner, M.; Pariante, C. M.; Pace, T. W.; Mercer, K. B.; Bradley, B.; Nemeroff, C. B.; Holsboer, F. et al.; Heim, C. M.; Ressler, K. J.; Rein, T.; Binder, E. B.: Epigenetic Modification as Mediator of Gene-Childhood Trauma Interactions. In BIOLOGICAL PSYCHIATRY, 73 (9), p. 15S - 15S. 68th Annual Scientific Meeting of the Society-of-Biological-Psychiatry, San Francisco, CA, May 16, 2013 - May 18, 2013. Elsevier Inc., New York, NY 10010-1710 (2013)

Menke, A.; Kloiber, S.; Best, J.; Rex-Haffner, M.; Uhr, M.; Holsboer, F.; Binder, E. B.: The Impact of Weight on Differential Alterations of GR-Mediated FKBP5. In BIOLOGICAL PSYCHIATRY, 73 (9), p. 204S - 204S. ELSEVIER SCIENCE INC, 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA (2013)